Analog Devices NASDAQ:ADI Chair and Chief Executive Officer Vincent Roche sold 10,000 shares of company stock on April 1, 2026, at a per-share price of $318.14, resulting in proceeds of approximately $3.18 million. The sale was disclosed in a Form 4 filing with the Securities and Exchange Commission.
The filing notes that the disposition was carried out pursuant to a pre-established 10b5-1 trading plan that Roche adopted on May 23, 2025. On the same April 1 date, Roche also exercised options to purchase 10,000 shares of Analog Devices common stock at an exercise price of $94.41 per share, totaling $944,100. Those options were fully vested and exercisable and carry an expiration date of March 11, 2030.
After completing the sale and the option exercise, Roche's direct holdings in Analog Devices total 167,825.875 shares. In addition to his direct holdings, 23,515 shares are reported as held indirectly through the Vincent Roche 2024 Grantor Retained Annuity Trust.
Market context included in the filing and related reporting indicates ADI shares have gained roughly 79% over the past year and are trading at $318.34, giving the company a market capitalization of about $155.4 billion.
Investment research cited in the disclosures includes an InvestingPro analysis that finds the stock currently appears overvalued on Fair Value metrics. That analysis is available through a Pro Research Report that covers ADI along with more than 1,400 U.S. equities.
Separately, several broker-dealers and research firms have responded to Analog Devices' latest financial results with upward price-target revisions and commentary highlighting segment-level strength.
- Cantor Fitzgerald reported a modest earnings beat and a strong raise, calling out growth in automated test equipment, automotive dealer electronic fulfillment, and data center optical and power applications. The firm reiterated an Overweight rating and set a $400 price target, citing cyclical tailwinds.
- TD Cowen raised its price target to $400, pointing to robust datacenter-related segments, strength in the aerospace and defense business, and improved gross margins.
- Truist Securities increased its price target to $364 while maintaining a Hold rating, highlighting cyclical strength and a solid outlook for the first calendar quarter.
- Piper Sandler raised its price target to $360 and maintained a Neutral rating, attributing growth to AI and data center end-markets with particular strength in Automatic Test Equipment and DC Power.
- KeyBanc moved its target to $430 after citing strong first-quarter results and second-quarter guidance that exceeded expectations, driven by Communications and Consumer segments.
Taken together, these analyst updates reflect a favorable consensus among several firms about Analog Devices' recent performance and near-term potential, particularly in datacenter-related and industrial end-markets.
While the Form 4 filing documents the CEO's sale and option exercise, the material also records Roche's remaining direct and indirect holdings and references the stock's multiquarter appreciation and recent analyst activity. The filing and accompanying research references provide investors with contemporaneous disclosure of executive transactions and the market and analyst context surrounding ADI.